Clinical Features and Outcome of Mucormycosis
暂无分享,去创建一个
D. Galarza-Delgado | C. Cámara-Lemarroy | E. Rendón-Ramírez | R. Rodríguez‐Gutiérrez | A. Ayala-Cortés | L. García-Labastida | E. González-Moreno | Martha Lizeth Fraga-Hernández
[1] A. Shorr,et al. Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data , 2014, BMC Infectious Diseases.
[2] L. Pagano,et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[3] B. Spellberg,et al. Pathogenesis of mucormycosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] C. Elie,et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] D. Kontoyiannis,et al. Epidemiology and clinical manifestations of mucormycosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] P. Hamal,et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[7] A. Papadas,et al. Rhinocerebral mucormycosis: an update. , 2010, European review for medical and pharmacological sciences.
[8] A. Simon,et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. , 2009, The Journal of antimicrobial chemotherapy.
[9] B. Spellberg,et al. Recent advances in the management of mucormycosis: from bench to bedside. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] C. Romano,et al. Zygomycosis in Italy: A Survey of FIMUA-ECMM (Federazione Italiana Di Micopatologia Umana ed Animale and European Confederation of Medical Mycology) , 2009, Journal of chemotherapy.
[11] T. Turunç,et al. Eleven cases of mucormycosis with atypical clinical manifestations in diabetic patients. , 2008, Diabetes research and clinical practice.
[12] Patricia Muñoz,et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] A. Chakrabarti,et al. Mucormycosis in immunocompetent individuals: an increasing trend. , 2005, The Journal of otolaryngology.
[14] D. Kontoyiannis,et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] N. Katsilambros,et al. Mucormycosis: Ten-Year Experience at a Tertiary-Care Center in Greece , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[16] E. Abemayor,et al. Rhinocerebral Mucormycosis: Evolution of the Disease and Treatment Options , 1997, The Laryngoscope.
[17] F. Bosques-Padilla,et al. Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases , 1996, Journal of the Neurological Sciences.
[18] A. Welch,et al. STUDIES OF OPPORTUNISTIC FUNGI: I. INHIBITION OF RHIZOPUS ORYZAE BY HUMAN SERUM , 1961, The American journal of the medical sciences.